InMed Pharmaceuticals Inc. Share Price

InMed Pharmaceuticals Inc. Share Price

NASDAQ: INM | Micro Cap
$1.60
+$0.03 (1.91%) Last updated on 29 Oct, 2026 | 01:11 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

InMed Pharmaceuticals Inc. Stock Performance

Open
$1.63
Prev. Close
$1.57
Circuit Range
N/A
Day Range
$1.60 - $1.63
Year Range
$0.60 - $2.32
Volume
900
Average Traded
$1.62

InMed Pharmaceuticals Inc. Share Price Today

As of 29 October 2026, InMed Pharmaceuticals Inc.'s share price is $1.60. The stock opened at $1.63, compared to its previous close of $1.57. During today's trading session, InMed Pharmaceuticals Inc.'s share price traded between $1.60 and $1.63, with an average price of $1.61. Over the past 52 weeks, the stock has recorded a high of $2.32 and a low of $0.60. In terms of performance, InMed Pharmaceuticals Inc.'s share price has risen by 117.98% over the last six months and is down 14.44% on a year-on-year basis.

InMed Pharmaceuticals Inc. Share Price Chart

Line chart of the InMed Pharmaceuticals Inc. price trend over the selected period. The price rose overall, ranging from 1.61 to 1.61, ending at 1.61.
$1.60$1.63
L
Show Current Price
H

InMed Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Market Cap
$12.19M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.36
Revenue (TTM)
$0.00
Return On Equity (TTM)
-1208.60%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-262.43%

InMed Pharmaceuticals Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1.12$0.82$0.00$0.00
Net Profit-$1.73-$2.03-$2.97-$6.27
Net Profit Margin-154.46%-247.56%N/AN/A
Income ChangeN/A-17.34%-46.31%-111.11%

InMed Pharmaceuticals Inc. Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$4.14$4.60$0.00$0.00
Net Profit-$7.95-$7.68-$8.16-$12.99
Net Profit Margin-192.03%-166.96%N/AN/A
Income ChangeN/A3.40%-6.25%-59.19%

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

InMed Pharmaceuticals Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.35
$1.60
+19.40%
Sep 2026
$1.32
$1.34
-6.94%
Aug 2026
$1.47
$1.44
-2.04%
Jul 2026
$1.55
$1.47
-6.37%
Jun 2026
$1.56
$1.57
-0.95%
May 2026
$0.77
$1.58
+115.94%
Apr 2026
$0.65
$0.73
+13.80%
Mar 2026
$0.83
$0.65
-26.70%
Feb 2026
$1.11
$0.88
-19.27%
Jan 2026
$1.09
$1.09
+0.93%
Dec 2025
$1.29
$1.08
-19.10%
Nov 2025
$1.86
$1.33
-28.61%

INM Share Price FAQs